PlainPharmaWatch

CMS Open Payments · Tool

Sealonix Inc. vs Fisher Scientific Company L.L.C.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Sealonix Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 6,380, versus 424 for the other company. Its single largest recorded recipient represents 79.6% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Sealonix Inc.
HHI 6,380 · top recipient 79.6%
Ranked #250 of 1,838 companies by HHI
Fisher Scientific Company L.L.C.
HHI 424 · top recipient 15.5%
Ranked #1,355 of 1,838 companies by HHI

Payment Overview

Company A

Sealonix Inc.

Total Payments
$186.9K
% of Industry
0.0%
Transactions
31
Avg per Transaction
$6.0K
Recipients
19
Avg per Recipient
$9.8K
Payment Types
3
Top Payment Type
Space Rental or Facility Fees
Total Payments
$186.1K
% of Industry
0.0%
Transactions
307
Avg per Transaction
$606.20
Recipients
299
Avg per Recipient
$622.42
Payment Types
6
Top Payment Type
Debt Forgiveness

Highlighted values indicate the higher figure for each metric.

Total payments compared

Sealonix Inc. vs Fisher Scientific Company L.L.C. - total reported payments in CMS Open Payments PY2024

Sealonix Inc.$186.9KFisher Scientific Company L…$186.1K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Sealonix Inc.

Space Rental or Facility Fees $35.7K

79.6%

Travel and Lodging $6.7K

14.8%

Consulting Fee $2.5K

5.6%

Fisher Scientific Company L.L.C.

Debt Forgiveness $130.5K

70.2%

Honoraria $38.3K

20.6%

Gift $5.2K

2.8%

Food and Beverage $5.2K

2.8%

Travel and Lodging $4.7K

2.5%

Education $2.1K

1.2%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Sealonix Inc.

  1. 1

    Tufts Medical Center

    $35,712.55 · 6 txns

  2. 2

    BENJAMIN P JOHNSON

    $2,000.00 · 2 txns

  3. 3

    MOHD RAASHID A SHEIKH

    $1,280.44 · 2 txns

  4. 4

    SHANKAR LAKSHMAN

    $1,073.72 · 1 txns

  5. 5

    GAURAV BHARTI

    $909.40 · 1 txns

Fisher Scientific Company L.L.C.

  1. 1

    Childrens Hospital

    $28,887.67 · 15 txns

  2. 2

    PADMASHREE WOODHAM

    $9,779.63 · 5 txns

  3. 3

    Methodist Hospital

    $8,319.70 · 2 txns

  4. 4

    University Hospital

    $6,919.84 · 8 txns

  5. 5

    SUBBIAN KARUMANCHI

    $5,969.94 · 5 txns

Summary Comparison

Metric Sealonix Inc. Fisher Scientific Company L.L.C.
Total Payments $186.9K $186.1K
% of Industry Total 0.0% 0.0%
Transaction Count 31 307
Avg per Transaction $6.0K $606.20
Recipient Count 19 299
Avg per Recipient $9.8K $622.42
Payment Type Count 3 6
Top Payment Type Space Rental or Facility Fees Debt Forgiveness

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.